Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2022 Mar 23;20(12):2888–2894.e1. doi: 10.1016/j.cgh.2022.03.018

Figure 1:

Figure 1:

Symptom burden of extra-intestinal symptoms at baseline and end of study

**There was no statistical differences between the Tx groups at each time point – ANOVA

**The overall symptom burden decreased significantly P<0.01 (T-Test) from Baseline (V1) to the end point (V3) for all treatment arms